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Abstract
Members of the family of calcium dependent protein kinases (CDPK’s) are abundant in cer-
tain pathogenic parasites and absent in mammalian cells making them strong drug target
candidates. In the obligate intracellular parasite Toxoplasma gondii TgCDPK3 is important
for calcium dependent egress from the host cell. Nonetheless, the specific substrate
through which TgCDPK3 exerts its function during egress remains unknown. To close this
knowledge gap we applied the proximity-based protein interaction trap BioID and identified
13 proteins that are either near neighbors or direct interactors of TgCDPK3. Among these
was Myosin A (TgMyoA), the unconventional motor protein greatly responsible for driving
the gliding motility of this parasite, and whose phosphorylation at serine 21 by an unknown
kinase was previously shown to be important for motility and egress. Through a non-biased
peptide array approach we determined that TgCDPK3 can specifically phosphorylate ser-
ines 21 and 743 of TgMyoA in vitro. Complementation of the TgmyoA null mutant, which
exhibits a delay in egress, with TgMyoA in which either S21 or S743 is mutated to alanine
failed to rescue the egress defect. Similarly, phosphomimetic mutations in the motor protein
overcome the need for TgCDPK3. Moreover, extracellular Tgcdpk3mutant parasites have
motility defects that are complemented by expression of S21+S743 phosphomimetic of
TgMyoA. Thus, our studies establish that phosphorylation of TgMyoA by TgCDPK3 is
responsible for initiation of motility and parasite egress from the host-cell and provides
mechanistic insight into how this unique kinase regulates the lytic cycle of Toxoplasma
gondii.
Author Summary
Toxoplasma gondii can cause severe disease and death in the immunocompromised and in
those infected congenitally. Due to limitations of existing drugs there is a need for studying
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proteins that are unique and essential to the parasite. We recently established that
TgCDPK3, a member of a family of calcium dependent protein kinase present in plants
and some parasites but absent in human cells, regulates parasite egress from the host cell.
While it has been hypothesized that TgCDPK3 controls rapid exit from the host by phos-
phorylating proteins needed for activating motility, the particular substrates of this kinase
remained unknown. We have now applied an interaction trap system to identify the pro-
teins that are modified by this kinase, which include a parasite motor protein Myosin A
(TgMyoA). We show that TgCDPK3 specifically phosphorylates TgMyoA and this phos-
phorylation is important for parasite egress and motility.
Introduction
The phylum Apicomplexa encompasses numerous obligate intracellular parasites that pose a
significant health risk to animals and humans. Among these, Toxoplasma gondii is one of the
most widespread, infecting all warm-blooded animals including approximately one third of the
human population. Humans become infected congenitally or by ingestion of either environ-
mental oocysts, which are shed in the feces of cats, or tissue cysts in the undercooked meat of
infected animals. Most infections are asymptomatic during the acute stage but as to evade the
immune response the parasite converts to a latent encysted form, thus establishing a chronic
infection. In immunocompromised individuals and lymphoma patients, new infections or rup-
ture of pre-existing cysts can lead to life-threatening toxoplasmic encephalitis [1–3]. Addition-
ally, in congenital infections, toxoplasmosis can lead to blindness, severe neurological
problems, or even death, given the immature nature of the fetal immune system [4].
A significant portion of the pathogenesis observed during toxoplasmosis is a direct conse-
quence of the repeating cycles of invasion, division and egress that drive propagation of the
parasite through the infected organism [5]. As the parasites escape their host cell during egress,
the host membrane is ruptured resulting in cell death and an ensuing inflammatory response,
both of which contribute to the pathogenesis of this infection. Active egress from the host cell
involves parasite motility, cytoskeletal rearrangements within the parasite, and secretion from
specialized organelles known as the micronemes [6–9]. A pore forming protein secreted from
the micronemes, the perforin-like protein TgPLP1, facilitates egress by permeabilizing both the
parasitophorous vacuolar membrane (PVM) and host plasma membrane [10]. Secretion of
TgPLP1 and the initiation of motility during egress are regulated by calcium signaling, which is
evident by the fact that treatment of intracellular parasites with calcium ionophores induces
microneme secretion, motility and egress [6–9]. Calcium signaling in this parasite is quite dis-
tinct from what is typically observed in mammalian cells, involving plant-like factors such as
the phytohormone abscisic acid (ABA) [11] and members of the family of Calcium Dependent
Protein Kinases (CDPK) [12]. In particular, TgCDPK1 has been shown to be upstream of a sig-
naling pathway regulating microneme secretion during egress and invasion [13].
Recently, three research teams, ours among them, identified a second calcium dependent
protein kinase, TgCDPK3, as being critical for ionophore-induced egress (iiEgress) [14–16].
Through a series of selection and screens we isolated independent mutants that exhibit delayed
iiEgress, resistance to extracellular exposure to calcium ionophores, which usually renders par-
asites non-invasive, and a reduction in in vivo virulence [17]. Whole genome sequencing of
one of these mutant strains (MBE1.1) revealed a missense mutation that results in threonine
for isoleucine (T239I) change within the catalytic domain of TgCDPK3 [18, 19]. As expected
given the position of the mutated amino acid, this mutation significantly reduces the in vitro
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kinase activity of recombinant TgCDPK3 [14]. The critical role of TgCDPK3 as mediator of
egress was validated when introduction of a wild type copy of TgCDPK3 was found to comple-
ment the phenotypes observed in MBE1.1.
Localization of TgCDPK3 to the periphery of the parasite [14] would suggest that it could
phosphorylate membrane-associated proteins that influence egress, such as members of the
motility machinery and those that regulate calcium signaling and fluxes. To experimentally
determine the substrates of TgCDPK3 the relative phosphorylation site usage in wild type and
Tgcdpk3mutant parasites was determined by quantitative mass-spectrometry using stable iso-
tope labeling with amino acids in cell culture (SILAC) [20]. Comparisons of phosphorylation
sites in wild type (WT) and mutant strains were made for intracellular parasites with and with-
out ionophore. This analysis revealed 156 sites that are differentially phosphorylated between
WT and mutant parasites. Importantly, most of the differential phosphorylation between the
mutant and wild type strains is rescued in the complemented strain. A third of the phospho-
sites detected (51 of 156) showed a significant difference between WT and mutant parasites
even in the absence of ionophore, indicating that TgCDPK3 regulates biological processes
independent of iiEgress. This category includes proteins important for ion-homeostasis and
metabolism, which is supported by the observation that basal calcium levels are increased in
Tgcdpk3mutant parasites [20]. Among ionophore induced phosphosites that are more abun-
dant in the WT than in the mutant strains are many that could play a role in egress or parasite
motility such as Myosin A, F, and G, proteins of the inner membrane complex (IMC) [21] and
a recently discovered protein that associates with cortical microtubules, TrxL-1
(TGGT1_115220) [22]. Interestingly a recent study showed that one of these candidates, Myo-
sin A is phosphorylated in a calcium dependent manner at specific sites and that this phos-
phorylation event is important for parasite egress although the responsible kinase was not
identified [23]. The list of proteins less phosphorylated in TgCDPK3 mutants also includes cal-
cium-signaling proteins including a putative calmodulin (TGGT1_042450) and two calcium-
dependent kinases (TgCDPK2a and TgCDPK3 itself). These results show that TgCDPK3 plays
a pivotal role in regulating tachyzoite functions including, but not limited to, egress.
Given the complexity of the TgCDPK3-related phosphoproteome the mechanistic reason
for the egress defect observed in parasites lacking TgCDPK3 function remains unexplained. In
this study we define the TgCDPK3 interactome through the implementation of a proximity
based interaction protein trap and identify Myosin A (TgMyoA) as a TgCDPK3 substrate. We
show that TgCDPK3 specifically phosphorylates TgMyoA at Serines 21 and 743 in vitro and
that these phosphorylation events are important for parasite egress in vivo.
Results
TgCDPK3-BirA* is targeted to the parasite plasma membrane and is
functional
To identify putative substrates and interacting proteins of TgCDPK3 we utilized the BioID sys-
tem, which relies on fusing a protein of interest to a mutant version of the bacterial BirA biotin
ligase (BirA) [24]. This mutant version of BirA lacks specificity and thus promiscuously bioti-
nylates any protein within 10 nm of the fusion protein. Accordingly, we generated a construct
in which BirA is fused to the C-terminus of TgCDPK3 followed by a hemagglutinin (HA) epi-
tope tag (TgCDPK3-BirA-HA, aka BirA fusion). The BirA fusion construct was transfected
into the Tgcdpk3mutant strain MBE1.1 [14]. As a control we transfected a construct carrying
an HA tagged TgCDPK3 (TgCDPK3-HA) into MBE1.1 as well. Western blot using anti-HA
antibodies showed that our recombinant strains correctly express either TgCDPK3-HA or
TgCDPK3-BirA-HA, both migrating at the expected size (Fig 1A). Immunofluorescence
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assays showed that the fusion protein is targeted to parasite periphery similarly to what is
observed with TgCDPK3 (Fig 1B). Since we expressed the BirA fusion protein in a strain lack-
ing TgCDPK3 function we were able to test its functionality by its ability to complement the
egress phenotype observed in Tgcdpk3mutant strains [14]. After 2 minutes of exposure to the
calcium ionophore A23187, MBE1.1 parasites remained mostly intracellular (99.6%) while
those expressing TgCDPK3-HA or BirA fusion protein showed 100% and 96.4% egress
respectively (Fig 1C). Thus, we have generated a strain expressing a BirA fusion protein,
which localizes correctly and is functional in the context of egress.
TgCDPK3-BirA* biotinylates unique proteins within in the parasite
To identify putative TgCDPK3 interacting proteins we grew TgCDPK3-HA and BirA fusion-
expressing parasites in the presence of biotin. Lysates of both cultures were treated with RIPA
Fig 1. TgCDPK3-BirA* fusion protein is targeted to the plasmamembrane and is functional. A. Western blot analysis of the Tgcdpk3mutant strain
MBE1.1, or MBE1.1 complemented with either TgCDPK3-HA or TgCDPK3-BirA*-HA (BirA* fusion) using anti-HA antibody. The Toxoplasma protein SAG1
is used as loading control. B. Localization of TgCDPK3 and BirA* fusion protein in the Tgcdpk3mutant strain MBE1.1 was examined in intracellular parasites
by IFA using anti-HA antibody. TgGAP45 is a marker for the inner membrane complex. Scale bar, 2 μM. C. Intracellular parasites of the MBE1.1 strain, or
MBE1.1 complemented with either TgCDPK3-HA or the BirA* fusion were analyzed for egress efficiency by treating with the Ca2+ ionophore A23187 for 2
minutes. n = 3. Error bars, SEM. D. MBE1.1 parasites expressing either TgCDPK3-HA or TgCDPK3-BirA*-HA (BirA* fusion) were treated with biotin for 48
hours and biotinylated proteins were pulled down with streptavidin beads and analyzed by western using streptavidin-HRP antibody. Asterisks indicate
proteins uniquely biotinylated in MBE1.1 + TgCDPK3-BirA*-HA parasites.
doi:10.1371/journal.ppat.1005268.g001
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buffer and the supernatant was subjected to affinity purification with streptavidin conjugated
magnetic beads to trap the biotinylated proteins. Western blot of the precipitated material
showed that, in addition to proteins that were common between the TgCDPK3-HA and BirA
fusion protein expressing parasites, there were several proteins that appeared to be biotinylated
solely in the BirA fusion protein expressing parasites (Fig 1D). Having confirmed the presence
of various proteins exclusively biotinylated in the parasites expressing BirA fusion protein, we
scaled up the affinity purification of biotinylated proteins from parasites grown with biotin and
subjected the resulting material to mass spectroscopy analysis. This analysis identified six pro-
teins that were common between the two strains (S2 Table) and fourteen proteins that were
detected only in the MBE1.1 + TgCDPK3-BirA parasite sample including TgCDPK3, which
was expected as the BirA fusion would biotinylate itself (Table 1). Remarkably, seven of the
proteins identified through our approach were previously shown through a proteomic study to
be differentially phosphorylated between wild type and Tgcdpk3mutant parasites (Table 1, in
bold). Having identified these proteins through two independent approaches strongly suggests
that they might be direct substrates of TgCDPK3.
TgCDPK3 phosphorylates S21 and S743 of TgMyoA
Among the proteins that interact with TgCDPK3-BirA the top hit was Myosin A (TgMyoA),
which was also identified as less phosphorylated at serine 20 or 21 in the phosphroproteome of
parental and Tgcdpk3mutant parasites [20]. To further confirm that TgMyoA is less phosphor-
ylated in Tgcdpk3mutant parasites we performed Phos-tag gel electrophoresis, which involves
use of Phos-tag biomolecule that specifically binds phosphorylated proteins and retards their
migration in the gel [25]. Towards this goal, we harvested intracellular MBE1.1 (Tgcdpk3
mutant) or MBE1.1+TgCDPK3-HA parasites in presence of intracellular buffer and re-sus-
pended in either intracellular or extracellular buffer followed by incubation at 37°C for 2 min-
utes and examined the phosphorylation status of TgMyoA (Fig 2A). The results showed that
TgMyoA’s migration is significantly slower in extracellular conditions, indicating that it is
phosphorylated when parasites transition from intra- to extra-cellular conditions. Importantly,
this shift in migration of TgMyoA is reduced in the Tgcdpk3mutant strain, MBE1.1, confirm-
ing that TgMyoA is less phosphorylated in the absence of TgCDPK3 function (Fig 2A).
Table 1. Proteins uniquely biotinylated in BirA* fusion protein expressing parasites. In bold are those
that were previously determined to be differentially phosphorylated in strains lacking TgCDPK3 function (20).
ID Description No. of Peptides
TGGT1_235470 Myosin A 13
TGGT1_280410 3'5'-cyclic nucleotide PDE domain-containing protein 4
TGGT1_249900 Adenine nucleotide translocator, putative 7
TGGT1_206590 CDPK2A 3
TGGT1_223940 GAP45 4
TGGT1_289690 GAPDH1 2
TGGT1_212090 Hypothetical protein 4
TGGT1_310420 Hypothetical protein 1
TGGT1_289760 Hypothetical protein 3
TGGT1_313290 MORN repeat-containing protein 2
TGGT1_314780 Myosin G 5
TGGT1_232340 Protein phosphatase 2C domain-containing protein 8
TGGT1_231630 IMC4 1
doi:10.1371/journal.ppat.1005268.t001
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As a next step we set out to determine whether TgCDPK3 can phosphorylate TgMyoA and
TgGAP45, another protein that forms part of T. gondii’s motility complex [7], and was also
exclusively identified in the sample from biotin exposed TgCDPK3-BirA parasites. Towards
this goal we performed an in vitro phosphorylation assay using purified recombinant
TgCDPK3 and a non-biased overlapping peptide array covering the entire TgMyoA and
TgGAP45 sequences. Each peptide was 15 amino acids in length and tiled peptides were shifted
by 3 amino acids. The peptides (273 for TgMyoA and 78 for TgGAP45) were spotted on a
modified cellulose membrane using routine Fmoc (N-(9-fluorenyl)methoxycarbonyl) chemis-
try, deprotected and exposed to activated recombinant TgCDPK3 in presence of [γ-32P]ATP
and calcium. Peptide spots phosphorylation was quantified using phosphoimaging. For
Fig 2. TgCDPK3-dependent phosphorylation of TgMyoA in vivo and in vitro. A. Phosphorylation status of TgMyo-A in MBE1.1 and MBE1.1
+ CDPK3-WT parasites was analyzed using Phos-tag gel electrophoresis andWestern blot using antibody against TgMyoA. Parasites were manually
extracted from host cells and incubated in either intracellular (IC) or extracellular (EC) buffer for 2 minutes. B. Mapping of TgCDPK3 phosphorylation sites on
TgMyoA by tiled peptide array analysis using purified recombinant TgCDPK3. Phosphorylation intensity of 15 amino acid length peptides that span full-length
TgMyoA and are each shifted by 3 amino acid was detected using MultiGauge version 3.0. The serines and threonines in the two peptides that showed
phosphorylation signal more than 100 PSL/mm2 are indicated above the corresponding peaks. Fine mapping of TgCDPK3 phosphorylation sites on TgMyoA
is shown in C and D. Phosphorylation by recombinant TgCDPK3 was tested on peptides that contained single, double and triple mutations of T14, S20 and
S21 residues in the peptide 13ATALKKRSSDVDHAVD28 (C) and S743, S744 and S748 residues in the peptide 736AALRLLKSSKLPSEE750 (D) n = 3, Error
bars, SEM. (*P < .05, students t test).
doi:10.1371/journal.ppat.1005268.g002
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TgMyoA, two peptides (13ATALKKRSSDVDHAVD28 and 736AALRLLKSSKLPSEE750)
showed phosphorylation signal>100 PSL/mm2 (Fig 2B). By contrast, none of the peptides
spanning GAP45 showed significant phosphorylation signal (S1 Fig). TgCDPK3 is a serine
threonine kinase and in each of the two peptides of TgMyoA that were phosphorylated there
are 3 potential phosphorylation sites (Fig 2B). To determine the specific residues that are phos-
phorylated we generated mutated versions of both peptides that contained single, double or tri-
ple mutations where serine (S) or threonine (T) were mutated to the non-phosphorylable
residue alanine. In vitro phosphorylation of these mutant peptides with purified recombinant
TgCDPK3 showed that in the peptide 13ATALKKRSSDVDHAVD28, mutation of either T14 or
S20 does not affect phosphorylation signal while mutation of S21 results in complete loss of
phosphorylation (Fig 2C). In the second peptide 736AALRLLKSSKLPSEE750 mutation of S744
or S748 does not significantly affect phosphorylation while mutation of S743 leads to 96.4%
loss of phosphorylation signal (Fig 2D). These results indicate that TgCDPK3 can specifically
phosphorylate S21 and S743 residues of TgMyoA.
Previous studies have shown that in T. gondii, TgMyoA is phosphorylated at multiple sites
including S21 [20, 26]. However, TgMyoA S743 has not been previously reported as phosphor-
ylated in Toxoplasma parasites. To address whether S743 is phosphorylated in vivo we
immuno-precipitated the motor complex with an antibody against TgGAP45 and analyzed the
phosphorylation status of TgMyoA by mass spectrometry. The analysis indicated that S743 is
indeed phosphorylated in intracellular parasites as evidenced by phosphorylation status of the
first serine of the peptide 743SSKLPSEEYQLGKTMVFLK760 (S2 Fig).
Phosphorylation of S21 and S743 is important for parasite egress
Interestingly, it has been previously reported that genetic disruption of TgMyoA results in a
delay of ionophore-induced egress reminiscent of what is observed in Tgcdpk3mutant parasites
[9]. To determine the importance of phosphorylation of S21 and S743 of TgMyoA during
induced egress, a process that is regulated by TgCDPK3, we complemented a TgMyoA null
mutant strain with either wild type TgMyoA or TgMyoA in which either S21 or S743, or both
were mutated to alanine (Fig 3A). Immunofluorescence assays of parasites expressing the wild
type or mutant MyoA indicate that the transgenic proteins correctly localize to the inner mem-
brane complex (Fig 3B). Importantly, western blot analysis showed that wild type and mutant
TgMyoA are expressed at similar levels in these transgenic parasites (Fig 3C). We exposed
these transgenic parasite lines as well as the TgMyoA knockout strain (MyoA KO) to A23187
for 2 minutes to determine the efficiency of ionophore-induced egress. As expected, the
TgMyoA KO exhibited a strong egress defect (1% egress), which was complemented by expres-
sion of wild type TgMyoA (97.2% egress, Fig 3D). By contrast, the TgMyoA mutants TgMyoA
(S21A), TgMyoA(S743A), and TgMyoA(S21A+S743A) only partially rescued the egress phe-
notype with 69.8%, 59.5%, and 53% egress, respectively (Fig 3D). These results suggest that the
presence of a phosphorylatable serine at positions 21 and/or 743 of TgMyoA contributes to
Toxoplasma egress from host cells.
Phosphomimetic mutants of TgMyoA compensate lack of TgCDPK3
function
We next tested whether mutating S21 and/or S743 of TgMyoA to the phosphomimetic residue
aspartic acid could rescue the egress defect of Tgcdpk3mutant parasites. Because phosphomi-
metic residues (aspartic acid or glutamic acid) do not fully approximate the electronegativity
produced by phosphorylation, we employed the strategy of mutating two neighboring pairs of
amino acids to overcome the charge differential [27, 28]. Accordingly, we transfected the
ToxoplasmaMyosin A Is a TgCDPK3 Substrate
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Tgcdpk3mutant strain MBE1.1 with either a FLAG tagged wild type copy of TgMyoA or FLAG
tagged TgMyoA in which serine residues 20 and 21, 743 and 744, or 20, 21, 743 and 744 were
mutated to aspartic acid (Fig 4A). Immunofluorescence assays andWestern blots assays indi-
cated that all versions of TgMyoA were correctly targeted and expressed at equal levels (Fig 4B
and 4C). At 2 minutes of exposure to A23187, which is sufficient to induce egress of 100% of
wild type parasites (Fig 1C), MBE1.1 mutant parasites expressing wild type or phosphomimetic
MyoA showed only 0.4% and 3.6% egress respectively. Nonetheless, by 6 minutes of ionophore
treatment we saw a significant difference between the MBE1.1 mutant parasites expressing an
exogenous copy of wild type MyoA and those expressing the phosphomimetic versions of the
protein (Fig 4D). Induction of egress with A23187 for 6 minutes showed that nearly all (97.3%)
MBE1.1 parasites expressing the exogenous wild type copy of MyoA remained inside of the
cells after six minutes of treatment. This indicates that overexpression of TgMyoA does not res-
cue the egress defect associated with lack of TgCDPK3 activity. By contrast, expression of either
TgMyoA SS(20–21)DD, TgMyoA SS(743–744)DD and TgMyoA S(20-21-743-744)D in
Fig 3. Phosphorylatable serines 21 and 743 of TgMyoA are important for iiEgress of Toxoplasma tachyzoites. A. Schematic representation of
TgMyoA with relative location of S21 and S743. B. TgMyoA null mutants were complemented with Flag-tagged wild type TgMyoA or Flag-tagged mutant
versions of TgMyoA. Localization of the Flag tagged transgenic TgMyoA was examined in intracellular parasites by IFA using anti-Flag antibody. TgGAP45 is
used as a marker for the IMC. Scale bar, 2 μM. C. Western blot analysis of TgMyoA null mutants complemented with either wild type or the mutant TgMyoA
was performed using anti-Flag antibody. SAG1 is used as loading control. D. Intracellular parasites of the TgMyoA null strain as well as those complemented
with either wild type TgMyoA or S21A, S743A or S(21+743)A mutant TgMyoA were analyzed for egress efficiency by treating with the Ca2+ ionophore
A23187 for 2 minutes. n = 3. Error bars, SEM. (*P < .05, students t test).
doi:10.1371/journal.ppat.1005268.g003
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MBE1.1 significantly complemented the ionophore induce egress phenotype (87%, 91.3%, and
86.7% egress at 6 minutes post induction respectively, Fig 4D). Thus, mimicking constitutively
phosphorylated TgMyoA partially overrides the need for TgCDPK3 function during calcium-
stimulated egress.
Phosphorylation of S21 and S743 of TgMyoA is important for parasite
motility
TgMyoA is an important component of glideosome and plays a critical role in parasite motility
[29, 30]. Thus, it is plausible one of the roles of TgCDPK3 during induced egress is to initiate
motility via the phosphorylation of TgMyoA. Interestingly, previous studies have shown that
chemical inhibition of TgCDPK3 affects initiation of motility in extracellular parasites [15].
Additionally, we have previously shown that Tgcdpk3mutant strains have reduced efficiency of
invasion [14, 17], a process that depends on motility. To further examine the role of TgCDPK3
in parasite motility, we tested the efficiency of the Tgcdpk3mutant strain (MBE1.1) and the
Fig 4. Constitutive phosphorylation of TgMyoA negates the requirement for TgCDPK3 during egress. A. Schematic representation of TgMyoA with
relative location of S20, S21 S743 and S744. IFA (B) and Western blot analysis (C) of Flag tagged TgMyoA in MBE1.1 (Tgcdppk3mutant) parasites
complemented with either wild type TgMyoA or SS20-21DD, SS743-744DD or S(20,21,743,744)D mutant TgMyoA was performed using anti-Flag antibody.
TgGAP45 is used as a marker for IMC in the IFAs and SAG1 is used as loading control in Western blot. Scale bar, 2 μM. D. Intracellular parasites were
analyzed for egress efficiency by treating with the Ca2+ ionophore A23187 for 6 minutes. n = 3. Error bars, SEM.
doi:10.1371/journal.ppat.1005268.g004
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complemented strain (MBE1.1+TgCDPK3) in transitioning from a non-motile to a motile
state. This was accomplished by recording and analyzing live video microscopy of parasites for
two minutes after changing the media from one that mimics intracellular conditions (IC
buffer) to one that mimics extracellular conditions (EC buffer) [31]. While 85.8% of the com-
plemented parasites had become motile by two minutes after switching the media, only 22.8%
of the TgCDPK3 mutant parasites were motile during the same time period (Fig 5A). Toxo-
plasma parasites normally exhibit three types of motility patterns referred to as helical, twirling
and circling [32]. Therefore, we scored the type of motility exhibited by those parasites of either
strain that were moving to determine whether TgCDPK3 played a role in a specific type of
movement. The results showed that the proportion of parasites exhibiting each type of move-
ment was similar between the two strains (Fig 5B). As we noted that the mutant parasites
appear to move at a slower pace than wild type ones, we also examined speed of parasite move-
ment when switched from intracellular to extracellular conditions. TgCDPK3 mutants moved
with an average speed of 0.21 μ/s while complemented parasites exhibited a much higher speed
of 1.15 μ/s (Fig 5C). Therefore, the large difference between the mutant and complemented
strains in the percentage of parasites that quickly initiated motility and also faster speeds con-
firm that TgCDPK3 plays a role in parasite motility.
We next wanted to determine if phosphomimetic mutants of TgMyoA could rescue the
motility defect in TgCDPK3 mutant parasites. For this we analyzed MBE1.1 parasites express-
ing an extra copy of either TgMyoA (WT) or TgMyoA S(20-21-743-744)D by video micro-
copy. The analysis showed that only 17.3% of MBE1.1 + TgMyoA (WT) parasites became
motile once transitioned from IC to EC buffer (Fig 5D). By contrast, MBE1.1 parasites comple-
mented with TgMyoA S(20-21-743-744)D showed increased levels of motility initiation with
56.6% of them becoming motile during the first two minutes after switching the buffer (Fig
5D). Quantification of three kinds of gliding motility between the two strains showed that the
proportion of each movement was similar between the two strains (Fig 5E). However, when
examined for speed, MBE1.1 + TgMyoA (WT) showed a pace of 0.1 μ/s while MBE1.1
+ TgMyoA S(20-21-743-744)D moved at a slightly higher speed of about 0.29 μ/s (Fig 5F).
These results indicate that phosphomimetics of TgMyoA can rescue the motility defect of
Tgcdpk3mutants at least in number of motile parasites suggesting they can compensate lack of
TgCDPK3 function in initiating parasite motility. However, as it is the case for iiEgress, this
rescue is not complete, as the speed of the MBE1.1 + TgMyoA S(20-21-743-744)D parasites is
still approximately threefold less than the wild type parasites.
Discussion
Although it is well established that TgCDPK3 is important for parasite egress, the particular
mechanism by which this calcium-stimulated kinase regulates this key event of the lytic cycle is
not known. A recent study revealed 156 phosphorylation sites out of more than 12,000 quanti-
fied that were differentially phosphorylated between wild type and Tgcdpk3mutant parasites,
with many of them related to motility, ion-homeostasis and metabolism [20]. While some of
these differentially phosphorylated sites might be direct substrates of TgCDPK3, one might
expect that a number of these sites related to downstream effects and compensatory mecha-
nisms related to a loss in TgCDPK3 signaling. In addition, TgCDPK3 is involved in several pro-
cesses such as calcium homeostasis and parasite division, which might involve distinct
substrates from those involved in egress. Therefore, additional efforts were needed to identify
the specific protein(s) whose phosphorylation by TgCDPK3 is key for induced egress and initi-
ation of motility. With this in mind we successfully adapted the BioID system to identify puta-
tive substrates and interactors of TgCDPK3. This approach, which is based on fusing the
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protein of interest to a promiscuous allele of the biotin ligase BirA, has the advantage that it
can identify not only direct interactors but also proteins that are nearby or interact loosely or
transiently, such as enzyme substrates. Identification by proximity labeling does not prove an
enzyme/substrate relationship, and it is plausible that some of these interactions are structural
in nature. However, in combination with our previous phosphoproteome analysis [20], which
identified seven of the thirteen proteins identified through BioID as less phosphorylated in
Tgcdpk3mutant parasites, it provides important indirect evidence for a kinase/ substrate rela-
tionship. Having been linked to TgCDPK3 in two independent and distinct approaches makes
these seven proteins strong candidates for being TgCDPK3 substrates during the events regu-
lated by this kinase.
These seven putative substrates include TgCDPK2a, GAPDH1, a MORN repeat containing
protein, IMC4, TgMyoA and TgMyoG, and a hypothetical protein of unknown function. Inter-
estingly, many of these proteins are known or would be predicted to be within the periphery of
Fig 5. TgCDPK3 is required for initiation of motility.Quantification of parasite motility by 2D live video microscopy when parasites are switched from
intracellular buffer to extracellular buffer condition (A and D). Parasite motility is shown as the mean percentage of total number of parasites that exhibited
motility or no motility. Quantification of different forms of motility exhibited by parasites when parasites are switched from intracellular buffer to extracellular
buffer condition (B and E). Parasite motility is shown as the mean percentage of total number of motile parasites that exhibited motility (helical, twirling and
circular gliding). Speed of parasite gliding when parasites are switched from intracellular to extracellular conditions (C and F). n = 3, Error bars = SEM. (*P <
.05, students t test).
doi:10.1371/journal.ppat.1005268.g005
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the parasite, which strengthens the argument that they might be TgCDPK3 substrates. For
example, IMC4 is part of the inner membrane complex [33], which is a continuous layer of flat
vesicles sutured together and to which the motor protein TgMyoA is anchored [30]. The glyc-
eraldehyde 3-phosphate dehydrogenase 1 (TgGAPDH1), which is normally cytoplasmic, redis-
tributes to the periphery of the parasite during egress [31]. Additionally, both the MORN
repeat-containing protein and the hypothetical proteins (TgGT1_310420) are predicted to be
myristoylated, which suggests membrane localization. The function of the hypothetical protein
is not known, but MORN proteins are involved in cell division in eukaryotes including T. gon-
dii [34, 35]. Interestingly, among the putative substrates identified in both the proteome and
the BioID approaches, is a second calcium dependent protein kinase (TgCDPK2a), which sug-
gests that these kinases might work together as co-regulators of a protein network or as part of
a signaling cascade. Nonetheless, at present no information as to either the localization or the
function of TgCDPK2a is available.
Of special interest among the proteins identified through BioID are TgMyoA and GAP45,
both of which form part of the motor complex driving the parasite’s gliding motility. The so-
called glideosome resides in the space between the parasite plasma membrane and the IMC
and it is a complex of several proteins including TgMyoA, two associated light chains, myosin
light chain TgMLC1 and essential light chain TgELC1 and the glideosome associated proteins
TgGAP40, TgGAP50, TgGAP45 or TgGAP70 [7, 30, 36, 37]. Given the proximity of TgCDPK3
to the glideosome and the facts that induced egress is dependent on motility and that motility
is a calcium-dependent process, a functional connection between TgCDPK3 and the motility
machinery is a plausible one. Recent studies using a small molecule invasion enhancer that
causes an increase in intracellular Ca2+ showed that TgMyoA is phosphorylated in a calcium
dependent manner at specific residues, serine 20, 21 and 29 and that phosphorylation of serine
21 is important for ionophore induced egress and motility [26]. However the kinase that medi-
ates this phosphorylation process had not been known. Interestingly, TgCDPK3 had been con-
sidered as a likely candidate given the remarkably similar egress phenotype seen in both the
TgmyoA and Tgcdpk3mutant strains. Consistent with this idea peptides containing phosphor-
ylated serine 20 or 21 were found to be less abundant in Tgcdpk3mutant strains as compared
to the parental or complemented ones in proteomic studies [20]. This finding suggested that
the phosphorylation status of TgMyoA, at least for Ser20/21 may be coupled to TgCDPK3 sig-
naling. Our BioID and mutagenesis data suggests that TgMyoA is directly regulated by
TgCDPK3 and is thus a bona fide substrate for TgCDPK3.
Our data strongly argues for a direct relation between TgMyoA phosphorylation and
TgCDPK3. Based on our BioID results, TgMyoA either interacts with or is in close proximity
to TgCDPK3. Consistent with this idea; we show that recombinant TgCDPK3 can indeed
phosphorylate TgMyoA in vitro with preference for serines 21 and 743. While CDPKs can act
non-specifically in vitro, it is important to note that we did not detect significant phosphoryla-
tion of any of the other known phosphorylated amino acids of TgMyoA and of none of those
from TgGAP45, indicating that we are observing some level of specificity in our peptide array
assay. Interestingly, TgGAP45 was not observed as less phosphorylated in our mutant strains
[20]. Therefore, any interaction between TgCDPK3 and TgGAP45 is likely to be structural and
not enzymatic and the phosphorylation state of TgGAP45, which is important for its function
[38], is likely regulated by a different kinase.
Creating a version of TgMyoA that ‘looks’ phosphorylated overrides the need for
TgCDPK3, strongly indicating that this is the kinase responsible for modifying TgMyoA.
Nonetheless, the complementation of iiEgress by the phosphomimetic versions of TgMyoA is
partial. While the levels of egress and motility exhibited by the phosphomimetic expressing
strains are significantly higher than that of the CDPK3 mutant strain, they don’t reach wild
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type levels. There are several plausible reasons for this incomplete complementation of the iiE-
gress phenotype, including the fact that phosphomimetic mutations are not a perfect simula-
tion of phosphorylated serine [27, 28]. Also, phosphomimetic mutations that result in
constitutively active serine or threonine do not allow for dynamic changes of alternating phos-
phorylation and dephosphorylation events that might be occurring in vivo and are important
for function. Another possibility we must consider is that other amino acids within TgMyoA
are also regulated by TgCDPK3, but were not revealed in our in vitro assays. Finally, and most
likely, TgMyoA might not be the only substrate through which TgCDPK3 is exerting its regula-
tion of iiEgress and/or other kinases might work redundantly along with TgCDPK3. We have
previously shown that disruption of TgCDPK3 results in dysregulation of calcium homeostasis,
a phenotype not observed previously with any TgMyoA mutants, which could affect sensitivity
to the ionophore. We haven’t specifically tested whether TgMyoA has an effect on resting cal-
cium levels in this study but its involvement is unlikely given its predicted role as part of the
molecular motor that drives movement of the parasite. Several of the putative substrates we
identified including TgCDPK2A, Myosin-G and GAPDH1 are good candidates for influencing
egress and future work will focus on understanding their potential contribution to TgCDPK3
regulated events.
An interesting question that remains unanswered is the particular timing of the phosphory-
lation of TgMyoA by TgCDPK3. Does TgCDPK3 phosphorylate TgMyoA during intracellular
growth or does it occur upon induction of egress? Based on the results obtained using Phos-tag
(Fig 2A) it appears that there is a significant level of TgCDPK3-dependent phosphorylation of
TgMyoA upon the transition from intracellular to extracellular conditions, which mimics what
the parasite encounters during egress. Nonetheless, based on phosphoproteomic comparison
between wild type and Tgcdpk3mutant parasites, phosphorylated Ser21 is more abundant in
the wild type strain even in intracellular parasites not exposed to ionophore, which would sug-
gest this phosphorylation event occurs in the absence of egress induction. Interestingly, it has
been reported that phosphorylation of several amino acids in TgMyoA is dependent on Ser21
being phosphorylated first [26]. Thus, a plausible model that would explain these various
results is that TgCDPK3 phosphorylates TgMyoA at Ser21 in response to calcium fluxes that
occur during intracellular growth, and that upon induction of egress either TgCDPK3 or
another kinase further phosphorylates TgMyoA in a phospho-Ser21 dependent manner. Thus,
in the absence of TgCDPK3 phosphorylation of TgMyoA is significantly altered during egress
due to lack or reduction of Ser21 phosphorylation.
Another important standing question is how phosphorylation of TgMyoA at those two par-
ticular sites influences its function at the mechanistic level. The importance of phosphorylation
is well established for class II myosins, which are found in skeletal muscle. Nonetheless,
TgMyoA is quite divergent structurally from other myosins [39, 40] and therefore its regulation
is likely to be unique. TgMyoA is a single headed motor protein [41] that belongs to the class
XIVa myosin family which is unique to Apicomplexans and ciliates and the conserved motor
domain shares only about 23–34% homology with mammalian myosins [23, 39]. Class XIVa
myosins also lack the conserved glycine at the lever arm pivot point and have a shorter C-ter-
minal tail, which has been shown to be important for motor function in class II myosins [41].
In TgMyoA, Ser 21 is located in the N-terminal region whose role remains undefined, while
Ser 743 lies within the motor domain. It is feasible that phosphorylation of these residues either
results in structural modification of TgMyoA that in turn allows new protein-protein interac-
tions or activates its enzymatic activity both of which could be important for mechanochemical
function of TgMyoA. The recent successful expression and purification of recombinant
TgMyoA [42] will be particularly useful to investigate how phosphorylation influences the
function and biochemistry of this unique and key motor protein. Those new in vitromethods
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along with our novel discovery that TgCDPK3 phosphorylates TgMyoA within the parasite to
initiate egress, will provide a more complete understanding of how motility is tightly regulated
during the lytic cycle of this important human parasite.
Materials and Methods
Parasite cultures
Toxoplasma gondii tachyzoites were maintained by passage through human foreskin fibroblasts
(HFF, obtained from the American Tissue Culture Collection ATCC) in a humidified incuba-
tor at 37°C with 5% CO2. Normal growth medium consisted of DMEM supplemented with
10% fetal bovine serum, 2 mM L-glutamine and 50μg/ml of penicillin-streptomycin. Purifica-
tion of parasites was performed as previously described [43].
Plasmid constructs
Primers used in generating plasmid constructs described in this section are listed in supple-
mental table S1 (S1 Table). To generate the BirA fusion (TgCDPK3-BirA-HA),
CDPK3-BirA-HA was commercially synthesized (GenScript, USA), amplified by PCR using
specific primers (S1 Table) and directionally cloned downstream of the Tgcdpk3 promoter in
the vector, pTgcdpk3CDPK3-HA [43] using NcoI and PacI sites. The non-phosphorylable and
phosphomimetic mutants of TgMyoA were made using Lightning site directed mutagenesis kit
(Agilent Technologies) with primers listed in S1 Table and pmyoA-FLAGTgMyoA-WT/graBle
[23] as the parent plasmid. All resulting constructs were verified by restriction digestion and
sequencing.
Stable transfection
Plasmid constructs were linearized with the restriction enzyme KpnI, purified and electropo-
rated into T. gondii tachyzoites according to established protocols [44, 45]. Parasites trans-
fected with BirA fusion construct were cultured in presence of 50 μg/ml mycophenolic acid
(MPA) and 50 μg/ml xanthine and cloned by limiting dilution to obtain stably transformed
clones. When using vectors carrying the Ble gene as a selectable marker, transfected parasites
were added onto an HFF monolayer and allowed to grow without any drug selection until the
monolayer was lysed. Freshly egressed parasites were then washed with Hanks’s balanced salt
solution containing 10 mMHEPES and 0.1 mM EGTA (HHE) and extracellular parasites were
treated with 50 μg/ml phleomycin in DMEM for 4 hours at 37°C with 5% CO2. The parasites
were then added onto a HFF monolayer and cultured in the presence of 5 μg/ml phleomycin to
select drug resistant parasites, which were cloned by limiting dilution.
Affinity purification of biotinylated proteins
Affinity purification of biotinylated proteins was performed according to previously described
protocols with minor modifications [24, 46]. Briefly, parasites were cultured in growth medium
containing biotin (150 μg/ml) for 48 hours. Freshly egressed parasites (2.5 x 109) were then
washed with phosphate buffered saline (PBS) and lysed with 1 ml RIPA buffer (20 mM Tris-
HCl (pH 7.5), 150 mM NaCl, 1 mM Na2EDTA, 1 mM EGTA, 1% NP-40, 1% sodium deoxy-
cholate, 2.5 mM sodium pyrophosphate, 1 mM β-glycerophosphate, 1 mM Na3VO4) supple-
mented with complete protease inhibitor (Roche) and centrifuged at 16000 g for 15 minutes at
4°C. The supernatant was then transferred to a fresh tube and incubated with magnetic strepta-
vidin beads (Dynabeads Myone streptavidin C1 from Invitrogen) at 4°C for 12 hours with gen-
tle shaking. Beads were then collected with magnets and washed twice with wash buffer 1 (2%
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SDS), once with wash buffer 2 (0.1% deoxycholate, 1% Triton X-100, 500 mMNaCl, 1 mM
EDTA and 50 mMHEPES, pH 7.5), once with wash buffer 3 (250 mM LiCl, 0.5% NP-40, 0.5%
deoxycholate, 1 mM EDTA and 10 mM Tris pH 8.1), twice with wash buffer 4 (50 mM Tris,
pH7.4 and 50 mMNaCl) and twice with PBS, in that order. The beads were finally re-sus-
pended in 1 ml PBS and 10% of each sample was then boiled at 98°C for 5 minutes to separate
bound proteins from magnetic beads and eluted proteins were analyzed by either silver staining
or Western blotting using streptavidin-HRP before mass spectrometry.
Mass spectrometric analysis
Mass spectrometric analysis was carried out on a Thermo-Fisher Scientific LTQ Orbitrap
Velos Pro mass spectrometer (Thermo-Fisher Scientific, Waltham, MA) interfaced with a
Waters Acquity UPLC system (Waters, Milford, MA). The proteins bound to streptavidin
beads (biotinylated proteins) and IgG beads (TgMyoA) were directly digested by trypsin. Sam-
ples were first reduced with 10 mM DTT in 10 mM ammonium bicarbonate and then alkylated
with 55 mM iodoacetamide (prepared freshly in 10 mM ammonium bicarbonate). Alkylated
samples were digested by trypsin (Promega, Madison, WI) overnight at 37°C. Tryptic peptides
were first injected onto a C18 trapping column (NanoAcquity UPLC Trap column 180μm x
20mm, 5μm, Symmetry C18) and subsequently onto an analytical column (NanoAcquity
UPLC column 100μm x 100mm, 1.7μm BEH130 C18). Peptides were eluted with a linear gradi-
ent from 3 to 40% acetonitrile in water with 0.1% formic acid developed over 90 minutes at
room temperature at a flow rate of 500 nL/min, and the effluent was electro-sprayed into the
LTQ Orbitrap mass spectrometer. Blanks were run prior to the sample to make sure there were
no significant background signals from solvents or the columns. Database search against Toxo-
plasma gondii GT1 strain annotated proteins from ToxoDB (release 10.0, updated January 31,
2014) was performed using Sequest (Thermo-Fisher Scientific) search engine to identify bioti-
nylated proteins and TgMyoA post-translational modification analysis was performed using
the Thermo-Fisher Scientific Proteome Discoverer software (v2.0).
Purification of recombinant TgCDPK3
The N-HIS-tagged TgCDPK3 expression construct described previously [14] was transformed
into BL21-Rosetta (DE3)pLysS cells, which were then induced to express recombinant protein
at 37°C with IPTG. His tagged recombinant protein was purified under native conditions using
QIAexpress Ni-NTA fast start kit (Qiagen) according to manufacturer’s protocol. The kinase
activity of recombinant TgCDPK3 was examined using peptide substrate syntide-2 (PLARTLS-
VAGLPGKK, AnaSpec, Inc.) and exhibited a specific activity of 22.9 μmol/min/mg.
Peptide spot arrays
Peptide arrays were synthesized using SPOTs synthesis method and spotted onto a derivatized
cellulose membrane (Intavis) as described previously [47]. The peptide membrane was blocked
at room temperature for 30 minutes in binding buffer containing 5% BSA. Recombinant
TgCDPK3 (5nM) was added to 50mMHEPES, pH 7.4, 100mM NaCl, 10mMMgCl2, 100μM
ATP, 1mM CaCl2, 6μCi/ml [γ-32P]ATP and incubated at room temperature for 15 minutes.
The membrane was washed three times with 100mM sodium phosphate pH 7.0, 1M NaCl,
10mM EDTA and visualized using phosphorimaging (Fuji phosphor imager). The phosphory-
lation of each peptide was detected and quantified using Multi Gauge version 3.0 (Fujifilm).
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Immunoblotting
Parasite lysates were heated at 100°C for 5 minutes in SDS-PAGE sample buffer with 2%
2-mercaptoethanol and resolved on 4–20% gradient gel (Bio-Rad, Hercules, CA). Proteins
were transferred from the gel onto nylon membranes using a semidry transfer apparatus (Bio-
Rad, Hercules, CA) at 12 V for 30 minutes. After blocking with 5% (w/v) skim milk powder in
TBS, membranes were treated with rabbit anti-HA tag antibody (Cell Signaling Technology),
for 1 hour. Membranes were then washed and incubated with horseradish peroxidase (HRP)
conjugated goat-anti rabbit IgG (Sigma). After washing, membranes were treated with Super-
Signal West Pico chemiluminescent substrate (Pierce Chemical) and imaged using FluorChem
E (Proteinsimple) [43].
Buffer switch assay and Phos-tag polyacrylamide gel electrophoresis
Intracellular parasites 24 hours post-infection were harvested in intracellular buffer [31], fil-
tered with 3-μmNucleopore membrane, pelleted and re-suspended in either intracellular
buffer or extracellular buffer [31]. Parasites were then incubated at 37°C for 2 minutes and
immediately placed on ice followed by centrifugation at 1000 g for 10 min at 4°C. The parasite
pellet was then lysed with RIPA buffer containing phosphatase inhibitor, PhosSTOP (Roche)
followed by addition of SDS sample buffer containing β-meracaptoethanol and heated at
100°C for 5 min. To examine phosphorylation status of Myosin-A, Phos-tag gel electrophoresis
was carried out according to manufacturers instructions (Wako Chemicals, USA). Briefly
200 μM Phos-tag (Wako Chemicals, USA) and 100 μMMnCl2 were added to conventional
7.5% (w/v) acrylamide resolving gel and the gel was run at constant voltage at RT. The gel was
washed three times in SDS-PAGE running buffer containing 10 mM EDTA and once each in
running buffer and transfer buffer before transferring to a PVDF membrane for immunoblot-
ting using anti-MyosinA antibody.
Immunofluorescence microscopy
Immunofluorescence staining of intracellular parasites was performed according to previously
described procedures [48]. The primary antibodies used were: mouse anti-HA (Cell Signaling
Technology), and rabbit anti-GAP45 and rabbit anti-MLC1[23]. Secondary antibodies used
include: Alexa Fluor-594- or Alexa Fluor-488-conjugated goat anti-rabbit or goat anti-mouse
(Molecular Probes). Slides were viewed using a Nikon Eclipse E100080i microscope and digital
images were captured with Hamamatsu C4742-95 charge-coupled device camera using NIS
elements software.
Ionophore induced egress assay
The efficiency of egress after calcium ionophore treatment was determined using established
protocols [14]. Percent egress was determined by dividing the number of lysed vacuoles by the
total number of vacuoles for a sample.
Motility assay
Parasite motility assay was performed according to previously described methods [15, 23] with
some modifications. Briefly, 24-well plates were pre-coated with 75 μg/ml of BSA in water at
37°C for 30 minutes and washed three times with intracellular buffer [31]. Intracellular para-
sites 24 hours post-infection were harvested in presence of intracellular buffer, filtered with 3-
μmNucleopore membrane, pelleted and re-suspended in intracellular buffer. The parasites
were then added onto wells and allowed to settle for 20 minutes at 37°C and the plate was
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transferred onto a heated chamber (set at 37°C) of inverted microscope (Leica AF6000). The
intracellular buffer in the well containing extracellular parasites was gently aspirated and extra-
cellular buffer [31] was added. Forty seconds after exchanging the buffer, parasite motility was
imaged for 2 minutes at 2 frames per second using LAS X software. The movies were then man-
ually analyzed to determine parasites exhibiting either twirling or helical or circular gliding and
the number of parasites performing each type of motility was normalized to the total number
of parasites in each movie. The speed of the parasite gliding was determined by measuring the
distance travelled in a given time by three motile parasites in each of two separate movies per
strain. The experiments were repeated 3 times.
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S1 Fig. Mapping of TgCDPK3 phosphorylation sites on TgGAP45 by tiled peptide array
analysis using purified recombinant TgCDPK3. Phosphorylation intensity of 15 amino acid
length peptides that span full-length TgGAP45 and are each shifted by 3 amino acid was
detected using MultiGauge version 3.0.
(TIF)
S2 Fig. MS/MS fragmentation spectrum of Myosin A peptide containing Ser 743. The gli-
deosome complex, which includes MyoA, was immunoprecipitated from intracellular parasites
using an antibody against GAP45 and submitted to MS/MS. Spectrum of phosphorylated pep-
tide sequence 743pSSKLPSEEYQLGKTMVFLK760 of TgMyoA is shown. Asterisks indicate
dehydrated serine, tyrosine, and threonine residues. The dominant neutral loss of phosphoric
acid and water from the precursor ion and sequence specific fragment ions are labeled. The
presence of y-series ions (y-6, y-11, y-14, and y-18) suggests that the first serine residue is phos-
phorylated. Detected fragment ions are shown in red (b-ions) and blue (y-ions).
(TIF)
S1 Table. List of primers used in the study. All primers are in 5’ to 3’ orientation.
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